Tag Archives: azn

Pfizer Confirms Pursuit Of AstraZeneca; Stocks Jump

Pfizer (PFE) says it is trying to acquire fellow big pharma AstraZeneca, confirming an anonymously sourced report from last week. Pfizer stock was up 4.5% and AstraZeneca 15% in morning trading on the stock market today. Pfizer bid for AstraZeneca on Jan. 5, offering $76.62 a share in cash and stock. AstraZeneca turned that down, but Pfizer contacted it again on April 26, trying to restart talks. AstraZeneca (AZN) said in its own statement that

Pfizer, AstraZeneca Rise On Report Of Merger Talks

Big pharmas Pfizer (PFE) and AstraZeneca (AZN) were both up in early trading on the stock market today after word got out Sunday that Pfizer had offered $101 billion to buy its rival. Citing unnamed sources, the U.K.’s Sunday Times said that the two had been talking but that AstraZeneca had resisted the offer. Both companies declined to comment. The report set Wall Street abuzz with speculation. AstraZeneca, unlike some of its rivals, is still

AstraZeneca Q4 Mixed, But Alzheimer’s Drug Advances

British drug giant AstraZeneca (AZN) issued a mixed Q4 report and guidance Thursday morning, knocking down the stock, though some on Wall Street took notice of the fact that it’s advancing its Alzheimer’s disease candidate to phase-three testing. The company said Q4 revenue dropped 6% from the year-earlier quarter to $6.84 billion, missing analysts’ consensus of $6.91 billion. Core EPS of $1.23 a share beat estimates by a penny, but was down 21%